» Articles » PMID: 17763118

Mortality Among Persons with Schizophrenia in Sweden: an Epidemiological Study

Overview
Publisher Informa Healthcare
Specialties Pharmacology
Psychiatry
Date 2007 Sep 1
PMID 17763118
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of the study was to analyse 10-year mortality among persons with schizophrenia from an epidemiological perspective. This cohort study included all persons with schizophrenia (n=255) living in the northern catchment area in Uppsala in 1991, and 1275 subjects from the national population register matched for sex, age and living area. The prevalence of schizophrenia was 0.37% and the mortality rate for individuals with schizophrenia was higher than for referents: 23.0% vs. 11.2%. The higher mortality among those with schizophrenia was mainly the result of unnatural causes and cardiovascular disease, especially in men. Excess mortality from cardiovascular disease was more pronounced in middle age, irrespective of gender. Multivariate analysis revealed higher mortality among individuals with schizophrenia living in the city than among those living in less urbanized areas. People with schizophrenia die more often than those without schizophrenia from unnatural causes or circulatory diseases. Individuals with schizophrenia die sooner from circulatory diseases than those without schizophrenia. Having schizophrenia and living in the city also results in higher mortality than having schizophrenia and living in other areas. The risk of early death from circulatory disease needs to be studied in more detail to reveal the potential respective contributions of intrinsic patient vulnerability, lifestyle factors and side-effects from psychotropic drugs.

Citing Articles

The relationship between familial-genetic risk and pharmacological treatment in a Swedish national sample of patients with major depression, bipolar disorder, and schizophrenia.

Kendler K, Ohlsson H, Sundquist J, Sundquist K Mol Psychiatry. 2023; 29(3):742-749.

PMID: 38123723 DOI: 10.1038/s41380-023-02365-9.


The Nature of the Familial Risk for Psychosis in Bipolar Disorder.

Kendler K, Abrahamsson L, Sundquist J, Sundquist K Schizophr Bull. 2023; 50(1):157-165.

PMID: 37440202 PMC: 10754180. DOI: 10.1093/schbul/sbad097.


Psychiatric symptoms and mortality in older adults with major psychiatric disorders: results from a multicenter study.

Chene M, Sanchez-Rico M, Blanco C, De Raykeer R, Hanon C, Vandel P Eur Arch Psychiatry Clin Neurosci. 2022; 273(3):627-638.

PMID: 35723739 DOI: 10.1007/s00406-022-01426-4.


Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors.

Correll C, Solmi M, Croatto G, Schneider L, Rohani-Montez S, Fairley L World Psychiatry. 2022; 21(2):248-271.

PMID: 35524619 PMC: 9077617. DOI: 10.1002/wps.20994.


Schizotypy, Lifestyle Behaviors, and Health Indicators in a Young Adult Sample.

Dinzeo T, Thayasivam U Behav Sci (Basel). 2021; 11(12).

PMID: 34940114 PMC: 8698323. DOI: 10.3390/bs11120179.